Antivascular endothelial growth factor treatments for neovascular agerelated macular degeneration save sight, but does everyone get treated?

Robert P. Finger; Robyn H. Guymer

doi:10.5694/mja12.11295

Antivascular endothelial growth factor treatments for neovascular agerelated macular degeneration save sight, but does everyone get treated?

Robert P. Finger, Robyn H. Guymer

Research output: Contribution to journal › Letter › Other › peer-review

Original language	English
Pages (from-to)	260-261
Number of pages	2
Journal	The Medical Journal of Australia
Volume	198
Issue number	5
DOIs	https://doi.org/10.5694/mja12.11295
Publication status	Published - 18 Mar 2013
Externally published	Yes

Access to Document

10.5694/mja12.11295

Cite this

@article{32f2e20032424d2cb0472921ebb22a83,

title = "Antivascular endothelial growth factor treatments for neovascular agerelated macular degeneration save sight, but does everyone get treated?",

author = "Finger, {Robert P.} and Guymer, {Robyn H.}",

year = "2013",

month = mar,

day = "18",

doi = "10.5694/mja12.11295",

language = "English",

volume = "198",

pages = "260--261",

journal = "The Medical Journal of Australia",

issn = "0025-729X",